Hailin Huang

机构：University of Nottingham, Harbin Institute of Technology, Gilead Sciences (United States), Gilead Sciences (Australia)

发表论文 99 篇 · 总被引 1232 次 · h-index 20

代表论文

• Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study (2024 · The Lancet HIV · 被引 47)
• Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial (2024 · Clinical Infectious Diseases · 被引 20)
• Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy (2024 · AIDS · 被引 18)
• Review of Flux Modulation Linear Permanent Magnet Machines (2024 · IEEE Transactions on Transportation Electrification · 被引 12)
• Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab (2025 · The Journal of Infectious Diseases · 被引 8)
• Optimization and Comparison of 1 MW-Class PM Motors for Aircraft Propulsion Using Litz Wire and Hairpin Windings (2025 · IEEE Transactions on Magnetics · 被引 5)